PharmaVOICE - 
May 2008
Purchase Issue

In Every Issue
Last Word
Michael V. Novinski became President and CEO of Emisphere Technologies [...]
By
Talent Pool
Pharma POOL Dr. Isma BENATTIA New R&D Head at Wyeth’s [...]
By
On the Calendar
ONTHE CALENDAR May 1516 13th Annual Pharmaceutical &Biotech Licensing &Deal [...]
By
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES eDrugSearch has [...]
By
What’s New
NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Immune Tolerance Institute (ITI), [...]
By
PharmaTrax
Expansion in size and number of clinical trials. The increase [...]
By
The Fourth Hurdle: The Call for Pharmacoeconomic Data
Managed MARKETS What began as a movement by government payers [...]
By

Denise Myshko

PharmaOutlet
Study Coordinator A is an early adopter of technology on [...]
By

Gil Kampfer

PharmaOutlet
We’ve all heard the maxim, if you can’t say anything [...]
By

Maghan Cook

UpFront
SOURCE:CEGEDIMDENDRITE,BEDMINSTER,N.J. DTC ALERT Shift to Physician Offices, Online Programs Cegedim [...]
By
Letter from the Editor
Every month our goal is to feature thought leaders who [...]
By

Taren Grom, Editor

On The Cover

Bridging the Communication Gap Between Physicians & Patients
The Point of Care Problem At the point of care is probably the worst place for patient education: the physician is time con strained, the patient is nervous, and neither may have enough information to make good deci sions concerning the patient’s care.Filling this gap becomes the crucial factor in improving patient and physician communications. [...]
By

Robin Robinson

Features

17th Annual Partnerships with CROs
17th Annual Partnerships with CROs Hundreds of clinical development and outsourcing professionals gathered in Las Vegas for the annual conference. Attendees were treated to a packed lineup of workshops, tracks, and keynote addresses covering the hot topics in clinical research and development. .Elina Dunn and Noelle Layton from Novartis check out the exhibit hall during [...]
By
Resurrecting Overlooked Commercial Channels
For decades, many pharmaceutical battlegrounds have been dominated by the drug companies with the largest army of sales reps. If sales started to dip, they simply hired more primary care sales reps, and presto, they were back on top, says Matt Wallach, executive VP and general manager at Verticals onDemand. Undoubted ly, an effective product [...]
By
Dr. Bob Sliskovic — A Quest for Discovery
keeps scientists like Dr. Sliskovic in search of the next great compound. “The anticipation of success is an extreme ly powerful stimulant,” he says. “I’ve watched scientists receive the cruelest blows in terms of having a pet compound die, but the next morning they would be back and raring to go.” That resilience, persistence, and [...]
By

Kim Ribbink

Special Feature: Good Citizens
SPECIAL FEATURE CITIZENS THERE ARE MANY FACTORS THAT GO INTO MAKING A COMPANY A GOOD CORPORATE CITIZEN, FROM THE PRODUCTS THEY MAKE TO HOW THEY INTERACT WITH CUSTOMERS AND PARTNERS TO THEIR REPUTATION AS AN EMPLOYER. INCREASINGLY,LIFESCIENCES COMPANIES ARE PLACING AN EMPHASIS ON PHILANTHROPY AND VOLUNTEERISM AND ARE EAGERLY SEEKING WAYS TO GIVE BACK TO [...]
By

Kim Ribbink

Special Feature: HBA’s 2008 Rising Stars
BY TAREN GROM Nelson. CommonHealth. There is no magic formula, no set of qualities or attributes which when combined in exact pro portions spontaneously produces a leader. Cer tainly many leaders possess similar characteris tics — innovation, persuasion, charisma, etc. — but what sets a leader apart is her ability to harness her talents and [...]
By

Taren Grom, Editor

Mobile Marketing
Pfizer did it. Bayer is doing it. So are J&J, Novartis, and others.There is evidence that use of mobile market ing is slowly taking hold in the industry. As texting grows within the United States from teens BFFing and ^5ing to baby boomers using short codes to respond to ads, pharma is slowly SU2P (stepping [...]
By

Robin Robinson

Seeding Early-Stage Research
Future success in the pharmaceutical industry will hinge on the ability of companies to deliver novel products that meet patient needs. To do that, pharma companies are teaming up with biotech companies, launching their own biotech divisions, investing in genetics, and acquiring other companies, all in an attempt to leverage innovation. Now, a few companies [...]
By

Denise Myshko

FEEDBACK